TRCT
BRTX icon

Tower Research Capital (TRC)’s BioRestorative Therapies BRTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550 Buy
1,463
+1
+0.1% – ﹤0.01% 4998
2026
Q1 		$398 Buy
1,462
+356
+32% +$229 ﹤0.01% 4884
2025
Q4 		$1.3K Sell
1,106
-2,513
-69% -$3.35K ﹤0.01% 4720
2025
Q3 		$5.25K Buy
3,619
+2,341
+183% +$3.62K ﹤0.01% 4254
2025
Q2 		$2.13K Sell
1,278
-1,919
-60% -$3.33K ﹤0.01% 4693
2025
Q1 		$5.69K Buy
3,197
+1,620
+103% +$3.1K ﹤0.01% 4095
2024
Q4 		$2.25K Sell
1,577
-574
-27% -$888 ﹤0.01% 4880
2024
Q3 		$3.74K Sell
2,151
-2,644
-55% -$4.36K ﹤0.01% 4779
2024
Q2 		$9.73K Buy
4,795
+2,134
+80% +$3.08K ﹤0.01% 4213
2024
Q1 		$3.67K Buy
2,661
+1,817
+215% +$2.8K ﹤0.01% 4821
2023
Q4 		$1.47K Buy
+844
New +$1.61K ﹤0.01% 5376
2023
Q3 		– Sell
-740
Closed -$3.26K – 5960
2023
Q2 		$3.26K Sell
740
-472
-39% -$2.26K ﹤0.01% 5092
2023
Q1 		$4K Sell
1,212
-2,969
-71% -$9.11K ﹤0.01% 5049
2022
Q4 		$11K Buy
4,181
+1,927
+85% +$6K ﹤0.01% 3791
2022
Q3 		$7K Sell
2,254
-111
-5% -$345 ﹤0.01% 4870
2022
Q2 		$7K Buy
2,365
+1,435
+154% +$6.08K ﹤0.01% 4765
2022
Q1 		$5K Buy
+930
New +$4.01K ﹤0.01% 5022

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Tower Research Capital (TRC)'s BRTX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its BioRestorative Therapies (BRTX) stake by 0.07% in Q2 2026, adding 1 share and bringing the position to 1,463 shares worth $550. The position accounts for ﹤0.01% of the portfolio, ranked #4998.

Tower Research Capital (TRC) first reported a position in BRTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $11K in Q4 2022. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • Tower Research Capital (TRC) held 1,463 shares of BioRestorative Therapies worth $550 as of Q2 2026.
  • Tower Research Capital (TRC) bought 1 BioRestorative Therapies share in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4998 holding.
  • Tower Research Capital (TRC) first reported a position in BioRestorative Therapies in Q1 2022 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s BioRestorative Therapies position peaked at $11K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.